 |
|
|
| |
Serum Pro-C3 Is Associated With Hepatic Steatosis and
Fibrosis, and Responsive to Changes in Steatosis in Patients With NASH
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Michael Charlton,1 Anna Mae Diehl,2 Eric Lawitz,3 Bradley Freilich,4 Mitchell L. Shiffman,5 Naga Chalasani,6 Bilal Hameed,7 Stephen Caldwell,8 Mary Rinella,9 Tuan Nguyen,10
Andrew Billin,10 C. Stephen Djedjos,10 Robert P. Myers,10 G. Mani Subramanian,10 Zachary Goodman,11 Claude Sirlin,12 Nezam H. Afdhal13, Rohit Loomba12
1University of Chicago, IL; 2Duke Clinical Research Institute, Durham, NC; 3Texas Liver Institute, UT Health San Antonio, TX; 4Kansas City Research Institute, Kansas City, MO; 5Liver Institute of Virginia, Newport News, VA; 6Indiana University School of Medicine, Indianapolis, IN;
7University of California San Francisco, CA; 8University of Virginia, Charlottesville, VA; 9Northwestern Medicine, Chicago, IL; 10Gilead Sciences, Inc., Foster City, CA; 11Inova Fairfax Hospital, Falls Church, VA; 12UC San Diego, La Jolla, CA; 13Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
References
1. Karsdal MA, et al. Am J Physiol Gastrointest Liver Physiol 2016;311:G1009-17; 2. Nielsen MJ, et al. Liver Int 2015;35:429-37; 3. Loomba R,
et al. Hepatology 2017 Sep 11 [Epub]; 4. Loomba R, et al. EASL 2017, poster SAT-489; 5. Middleton MS, et al. EASL 2017, poster SAT-483.
|
| |
|
|
|
|
|
